According to the enterprise research app, Nanjing Haoyuan New Drug Research and Development Co., Ltd. was recently established. The legal representative is Zhou Zhiguo, with a registered capital of 10 million yuan. The business scope includes: medical research and experimental development; sales of specialty chemical products; new material technology research and development; import and export of goods, etc. Enterprise investigation and equity penetration revealed that the company is wholly owned by Haoyuan Pharmaceutical.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.